Compositions and uses of arginine depleting agents for cancer, obesity, metabolic disorders and related complications and complications

The present disclosure relates to arginase albumin binding domain (ABD) fusion proteins, methods of making and uses thereof. Methods involving arginine depletion for treating obesity, metabolic disorders and related complications and complications are also provided..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 24. Okt. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

LIANG RUNSONG [VerfasserIn]
SHEN XIUYUAN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-10-24, Last update posted on www.tib.eu: 2024-04-22, Last updated: 2024-04-26

Patentnummer:

CN116920081

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA003579611